MedTrace Logo

The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.

NCT06354101 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-04-09

No results posted yet for this study

Summary

The purpose of this registry study is to learn more about metabolic health. The information gathered will be used to support research on the natural history of obesity and weight related diseases, their treatments, and how it affects overall health. Approximately 15,000 participants who are overweight or have obesity with or without metabolic diseases are expected to participate in this registry study.

Conditions

  • Metabolic Health

Interventions

DRUG

Tirzepatide

Once-weekly subcutaneous injectable

DRUG

Semaglutide

Once-weekly subcutaneous injectable

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2023-07-01
Completion
2023-07-01

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06354101 on ClinicalTrials.gov